Therapeutic benefit of larotrectinib over the historical standard of care in patients with locally advanced or metastatic infantile fibrosarcoma (EPI VITRAKVI study)

DSpace Repository

Therapeutic benefit of larotrectinib over the historical standard of care in patients with locally advanced or metastatic infantile fibrosarcoma (EPI VITRAKVI study)

Author: Orbach, D.; Carton, M.; Khadir, S. K.; Feuilly, M.; Kurtinecz, M.; Phil, D.; Vokuhl, C.; Koscielniak, E.; Pierron, G.; Lemelle, L.; Sparber-Sauer, M.
Tübinger Autor(en):
Koscielniak, Ewa
Sparber-Sauer, Monika
Published in: Esmo Open (2024), Bd. 9 (5), Article 103006
Verlagsangabe: Amsterdam : Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/j.esmoop.2024.103006
ISSN: 2059-7029
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)